0001437749-22-015774.txt : 20220623 0001437749-22-015774.hdr.sgml : 20220623 20220623194759 ACCESSION NUMBER: 0001437749-22-015774 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211118 FILED AS OF DATE: 20220623 DATE AS OF CHANGE: 20220623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Diamandis Peter CENTRAL INDEX KEY: 0001528288 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41058 FILM NUMBER: 221036696 MAIL ADDRESS: STREET 1: 4640 ADMIRALTY WAY STREET 2: SUITE 500 CITY: MARINA DEL REY STATE: CA ZIP: 90292 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxxinity, Inc. CENTRAL INDEX KEY: 0001851657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862083865 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1717 MAIN STREET STREET 2: SUITE 3388 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: (254) 244-5739 MAIL ADDRESS: STREET 1: 1717 MAIN STREET STREET 2: SUITE 3388 CITY: DALLAS STATE: TX ZIP: 75201 4/A 1 rdgdoc.xml FORM 4/A X0306 4/A 2021-11-18 2021-11-18 0001851657 Vaxxinity, Inc. VAXX 0001528288 Diamandis Peter 1717 MAIN STREET SUITE 3388 DALLAS TX 75201 1 Class A common stock 2021-11-18 4 S 0 248 13 D 90499 D In the Form 4 filed on November 18, 2021, the Reporting Person omitted this sale of stock to cover fees in connection with the previously reported transaction. On November 18, 2021, the Reporting Person omitted this sale of stock to cover fees in connection with the previously reported transaction. /s/ Rene Paula Molina, attorney-in-fact for Peter Diamandis 2022-06-23